993 related articles for article (PubMed ID: 17712817)
1. Cannabis, pain, and sleep: lessons from therapeutic clinical trials of Sativex, a cannabis-based medicine.
Russo EB; Guy GW; Robson PJ
Chem Biodivers; 2007 Aug; 4(8):1729-43. PubMed ID: 17712817
[TBL] [Abstract][Full Text] [Related]
2. Oromucosal delta9-tetrahydrocannabinol/cannabidiol for neuropathic pain associated with multiple sclerosis: an uncontrolled, open-label, 2-year extension trial.
Rog DJ; Nurmikko TJ; Young CA
Clin Ther; 2007 Sep; 29(9):2068-79. PubMed ID: 18035205
[TBL] [Abstract][Full Text] [Related]
3. Cannabis-based medicines--GW pharmaceuticals: high CBD, high THC, medicinal cannabis--GW pharmaceuticals, THC:CBD.
Drugs R D; 2003; 4(5):306-9. PubMed ID: 12952500
[TBL] [Abstract][Full Text] [Related]
4. A tale of two cannabinoids: the therapeutic rationale for combining tetrahydrocannabinol and cannabidiol.
Russo E; Guy GW
Med Hypotheses; 2006; 66(2):234-46. PubMed ID: 16209908
[TBL] [Abstract][Full Text] [Related]
5. Randomized, controlled trial of cannabis-based medicine in central pain in multiple sclerosis.
Rog DJ; Nurmikko TJ; Friede T; Young CA
Neurology; 2005 Sep; 65(6):812-9. PubMed ID: 16186518
[TBL] [Abstract][Full Text] [Related]
6. Medicinal cannabis extracts for the treatment of multiple sclerosis.
Smith PF
Curr Opin Investig Drugs; 2004 Jul; 5(7):727-30. PubMed ID: 15298068
[TBL] [Abstract][Full Text] [Related]
7. THC and CBD oromucosal spray (Sativex®) in the management of spasticity associated with multiple sclerosis.
Sastre-Garriga J; Vila C; Clissold S; Montalban X
Expert Rev Neurother; 2011 May; 11(5):627-37. PubMed ID: 21456949
[TBL] [Abstract][Full Text] [Related]
8. Initial experiences with medicinal extracts of cannabis for chronic pain: results from 34 'N of 1' studies.
Notcutt W; Price M; Miller R; Newport S; Phillips C; Simmons S; Sansom C
Anaesthesia; 2004 May; 59(5):440-52. PubMed ID: 15096238
[TBL] [Abstract][Full Text] [Related]
9. Cannabis derivatives and pain. A small role for delta9-tetrahydrocannabinol (THC) in some forms of multiple sclerosis.
Prescrire Int; 2009 Oct; 18(103):226. PubMed ID: 19882800
[No Abstract] [Full Text] [Related]
10. Heat exposure of Cannabis sativa extracts affects the pharmacokinetic and metabolic profile in healthy male subjects.
Eichler M; Spinedi L; Unfer-Grauwiler S; Bodmer M; Surber C; Luedi M; Drewe J
Planta Med; 2012 May; 78(7):686-91. PubMed ID: 22411724
[TBL] [Abstract][Full Text] [Related]
11. Cannabis; adverse effects from an oromucosal spray.
Scully C
Br Dent J; 2007 Sep; 203(6):E12; discussion 336-7. PubMed ID: 17703180
[TBL] [Abstract][Full Text] [Related]
12. Sativex for the management of multiple sclerosis symptoms.
Perras C
Issues Emerg Health Technol; 2005 Sep; (72):1-4. PubMed ID: 16317825
[TBL] [Abstract][Full Text] [Related]
13. Neuroprotective effects of phytocannabinoid-based medicines in experimental models of Huntington's disease.
Sagredo O; Pazos MR; Satta V; Ramos JA; Pertwee RG; Fernández-Ruiz J
J Neurosci Res; 2011 Sep; 89(9):1509-18. PubMed ID: 21674569
[TBL] [Abstract][Full Text] [Related]
14. Symptomatic treatment of multiple sclerosis using cannabinoids: recent advances.
Smith PF
Expert Rev Neurother; 2007 Sep; 7(9):1157-63. PubMed ID: 17868014
[TBL] [Abstract][Full Text] [Related]
15. Effects of acute oral Delta9-tetrahydrocannabinol and standardized cannabis extract on the auditory P300 event-related potential in healthy volunteers.
Roser P; Juckel G; Rentzsch J; Nadulski T; Gallinat J; Stadelmann AM
Eur Neuropsychopharmacol; 2008 Aug; 18(8):569-77. PubMed ID: 18544469
[TBL] [Abstract][Full Text] [Related]
16. Sativex: clinical efficacy and tolerability in the treatment of symptoms of multiple sclerosis and neuropathic pain.
Barnes MP
Expert Opin Pharmacother; 2006 Apr; 7(5):607-15. PubMed ID: 16553576
[TBL] [Abstract][Full Text] [Related]
17. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
[TBL] [Abstract][Full Text] [Related]
18. Abuse potential and psychoactive effects of δ-9-tetrahydrocannabinol and cannabidiol oromucosal spray (Sativex), a new cannabinoid medicine.
Robson P
Expert Opin Drug Saf; 2011 Sep; 10(5):675-85. PubMed ID: 21542664
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of two cannabis based medicinal extracts for relief of central neuropathic pain from brachial plexus avulsion: results of a randomised controlled trial.
Berman JS; Symonds C; Birch R
Pain; 2004 Dec; 112(3):299-306. PubMed ID: 15561385
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the safety and tolerability profile of Sativex: is it reassuring enough?
Wade D
Expert Rev Neurother; 2012 Apr; 12(4 Suppl):9-14. PubMed ID: 22509986
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
